Admission Date:  [**2160-7-7**]              Discharge Date:   [**2160-7-15**]   Service: CARDIOTHORACIC  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1283**] Chief Complaint: Fatigue/Dyspnea on exertion  Major Surgical or Invasive Procedure: [**2160-7-9**] - Coronary artery bypass graft x3 (free left internal mammary artery from vein graft to left anterior descending coronary artery, reverse saphenous vein single graft from the aorta to the first obtuse marginal coronary artery and reverse saphenous vein graft from the aorta to the distal right coronary artery).
He underwent a cardiac catheterization which rvealed three vessel diesase and he was referred for surgical management.
Pacer pocket in right upper chest.
5.The aortic valve leaflets (3) are mildly thickened but aortic stenosis is  not present.
Patient is v paced and receiving an infusion of phenylephrine.
Aorta intact post decannulation  [**2160-7-14**] 06:10AM BLOOD WBC-9.6 RBC-3.26* Hgb-10.2* Hct-30.0* MCV-92 MCH-31.4 MCHC-34.1 RDW-15.8* Plt Ct-174 [**2160-7-15**] 06:00AM BLOOD PT-20.2* PTT-35.5* INR(PT)-1.9* [**2160-7-14**] 06:10AM BLOOD PT-18.6* PTT-33.7 INR(PT)-1.8* [**2160-7-13**] 04:50AM BLOOD PT-16.2* INR(PT)-1.5* [**2160-7-12**] 08:12AM BLOOD PT-14.9* PTT-32.7 INR(PT)-1.3* [**2160-7-15**] 06:00AM BLOOD Glucose-128* UreaN-46* Creat-1.5* Na-142 K-4.5 Cl-106 HCO3-24 AnGap-17 [**2160-7-14**] 06:10AM BLOOD Glucose-120* UreaN-51* Creat-1.7* Na-141 K-5.0 Cl-106 HCO3-23 AnGap-17 [**2160-7-13**] 04:50AM BLOOD Glucose-81 UreaN-37* Creat-1.4* Na-142 K-4.1 Cl-107 HCO3-23 AnGap-16  Brief Hospital Course: Rabbi [**Known lastname **] was admitted to the [**Hospital1 18**] on [**2160-7-7**] for surgical management of his coronary artery disease.
Heparin was started as his INR was allowed to normalize.
On [**2160-7-9**] Rabbi [**Known lastname **] was taken to the operating room where he underwent coronary artery bypass grafting to three vessels.
He was transfused with packed red blood cells for postoperative anemia.
Coumadin was resumed for his chronic atrial fibrillation.
Dr. [**Last Name (STitle) **] will resume his coumadin management as per preoperatively upon discharge from rehabilitation.
Medications on Admission: Enalapril 10mg QD Atenolol 50mg QD Coumadin 7.5mg QD Lipitor 20mg QD Glipizide 10mg QD Actos 30mg QD Colchicine 0.6mg PRN Lasix 20mg QD FLomax 0.4mg QD Diovan 80mg QD  Discharge Medications: 1.
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Tamsulosin 0.4 mg Capsule, Sust.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Glipizide 5 mg Tab,Sust Rel Osmotic Push 24hr Sig: Two (2) Tab,Sust Rel Osmotic Push 24hr PO DAILY (Daily).
Pioglitazone 15 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Tramadol 50 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed.
Warfarin 5 mg Tablet Sig: One (1) Tablet PO ONCE (Once) for 1 doses.
These include redness, drainage or increased pain.
4)  No lotions, creams or powders to incision until it has healed.
Use sunscreen on incision if exposed to sun.
7) Coumadin to be taken daily.
Please resume coumadin follow-up with Dr. [**Last Name (STitle) **] ([**Telephone/Fax (1) 73689**].
8) Take lasix and potassium once daily for 5 days then stop.
Monitor and replete electrolytes as needed.
([**Telephone/Fax (1) 1504**] Follow-up with cardiologist Dr. [**Last Name (STitle) **] in [**12-11**] weeks for routine appointment and immediately after discharge from rehab for coumadin management.
